Clinical Trial Update: Research of Exenatide for Overweight/Obese PCOS Patients With IGR [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating exenatide for overweight/obese polycystic ovary syndrome patients with impaired glucose regulation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorder of Glucose Regulation
• Obesity
• Polycystic Ovary Syndrome

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: RenJi Hospital | Conditions: Polycystic Ovary Syndrome, Overweight and Obesity | Phase 4 | Status: COMPLETED